Drug Shortage Report for MYLAN-TADALAFIL
Report ID | 73957 |
Drug Identification Number | 02410656 |
Brand name | MYLAN-TADALAFIL |
Common or Proper name | TADALAFIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 4BL CA |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2019-06-06 |
Actual start date | |
Estimated end date | 2019-08-30 |
Actual end date | 2019-06-18 |
Shortage status | Resolved |
Updated date | 2019-06-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v49 | 2019-06-19 | English | Compare |
v48 | 2019-06-18 | French | Compare |
v47 | 2019-06-18 | English | Compare |
v46 | 2019-06-07 | English | Compare |
v45 | 2019-06-04 | French | Compare |
v44 | 2019-06-04 | English | Compare |
v43 | 2019-06-01 | English | Compare |
v42 | 2019-05-28 | French | Compare |
v41 | 2019-05-28 | English | Compare |
v40 | 2019-05-28 | English | Compare |
v39 | 2019-05-22 | French | Compare |
v38 | 2019-05-22 | English | Compare |
v37 | 2019-05-21 | English | Compare |
v36 | 2019-05-14 | French | Compare |
v35 | 2019-05-14 | English | Compare |
v34 | 2019-05-14 | English | Compare |
v33 | 2019-05-08 | French | Compare |
v32 | 2019-05-08 | English | Compare |
v31 | 2019-04-30 | French | Compare |
v30 | 2019-04-30 | English | Compare |